Therapeutic electromagnetic field effects on angiogenesis during tumor growth: A pilot study in mice

Electromagnetic Biology and Medicine

Volumn 20, Issue 3, 2001, Pages 323-329

  Williams, C Douglas ^a   Markov, Marko S ^a  

^a EMF Therapeutics Inc   (United States)

Author keywords

Angiogenesis; Cancer; Electromagnetic fields; Magnetic fields

Indexed keywords

ANIMALIA; MURINAE;

EID: 0346608602     PISSN: 15368378     EISSN: None     Source Type: Journal    
DOI: 10.1081/JBC-100108573     Document Type: Article

References (19)

1. Bassett, C.A.L. Fundamental and Practical Aspects of Therapeutic Uses of Pulsed Electromagnetic Fields, Crit. Rev. Biomed. Eng. 1989, 17, 451-529.
2. Bassett, C.A.L. Bioeiectromagnetics in the Service of Medicine. In Electromagnetic Fields. Biological Interactions and Mechanisms; Blank, M., Ed.; American Chemical Society: Washington, DC, 1995; 261-176.
3. Folkman, J. Clinical Application of Research on Angiogenesis. N. Engl. J. Med. 1995, 333, 1757-1763.
4. O'Reilly, M.S.; Holmgren, L.; Chen, C.; et al. Angiostatin Induces Canal Sustain Dormancy of Human Tumors in Mice. Nat. Med. 1996, 2, 689-692.
5. Boehm, T.; Folkman, J.; Browder, T.; O'Reilly, M.S. Antiangiogenic Therapy of Experimental Cancer Does Not Induce Acquired Drug Resistance. Nature 1997, 390, 404-407.
6. Corbett, T.H.; Griswood, D.P., Jr.; Roberts, B.J.; Peckham, J.C.; Schabel, F.M., Jr. Biology and Therapeutic Response of a Mouse Mammary Adenocarcinoma (16/C) and Its Potential as a Model for Surgical Adjuvant Chemotherapy. Cancer Treat. Rep. 1978, 62, 1471-1488.
7. Teicher, B.A., Ed. Anticancer Drug Development Guide; Humana Press: Totowa, NJ, 1997.
8. Vanzulii, S.; Cazzaniga, S.; Braidot, M.F.; Vecchi, A.; Montovani, A.; Weinstok de, Calmanovici, R. Detection of Endothelial Cells by MEC 13.3 Monoclonal Antibody in Mice Mammary Tumors. Biocell 1997, 21, 39-46.
9. De Seze, R.; Tuffet, S.; Moreau, J.M.; Veyret, B. Effect of 100 mT Time Varying Magnetic Fields on the Growth of Tumors in Mice. Bioelectromagnetics 2000, 21, 107-111.
10. Ruifrok, A.C. Quantification of Immunohistochemical Staining by Color Translation and Automated Thresholding. Anal. Quant. Cytol. Histol. 1997, 19, 107-113.
11. De Lisser, H.M.; Christofidou-Solomidou, M.; Strieter, R.M.; Burdick, M.D.; Robinson, C.S.; Wexler, R.S.; Kerr, J.S.; Garlanda, C.; Merwin, J.R.; Madri, J.A.; Albelda, S.M. Involvement of Endothelial PECAM-1/CD31 in Angiogenesis. Am. J. Pathol. 1997, 151, 671-677.
12. Charpin, C.; Garcia, S.; Bouvier, C.; Andras, L.; Bonnier, P.; Lavaut, M-N.; Allasia, C. CD31/PECAM Automated and Quantitative Immunochemical Assay in Breast Carcinomas. Am. J. Clin. Pathol. 1997, 107, 534-540.
13. Hauser, I.A.; Riess, R.; Hausknecht, B.; Thuringer, H.; Sterzel, R.B. Expression of Cell Adhesion Molecules in Primary Renal Disease and Renal Allograft Rejection. Nephrol. Dial. Transplant. 1997, 12, 1122-1131.
14. Sersa, G.; Cemazar, M.; Parkins, C.S.; Chalpin, D.L. In Tumor Blood Flow Changes Induced by Application Of Electrical Pulses, Proceedings of the IV EBEA Congress, Zagreb, Croatia, 1998; 24-25.
15. Hannan, C.J.; Liang, Y.; Allison, J.D.; Pantazis, C.G.; Searle, J.R. Chemotherapy of Human Carcinoma Xenografts During Pulsed Magnetic Field Exposure. Anticancer Res. 1994, 14, 1521-1524.
16. Bawin, S.M.; Adey, W.R. Sensitivity of Calcium Binding in Cerebral Tissues to Weak Environmental Electromagnetic Fields Oscillating at Low Frequency. Proc. Natl. Acad. Sci. U.S.A. 1976, 73, 1999-2003.
17. Markov, M.S.; Todorov, S.I.; Ratcheva, M.R. Biomagnetic Effects of the Constant Magnetic Field Action on Water and Physiological Activity. In Physical Bases of Biological Informational Transfer; Jensen, K., Vassileva, Y., Eds.; Plenum Press: New York, 1976; 441-445.
18. Garkavi, L.X.; Kvakina, E.B.; Ukolova, M.A. The Adaptive Reaction and Resistance of the Organism. Rostov University Press: Rostov on Don, 1990.
19. Markov, M.S. Influence of Radiation on Biological Systems. In Charge and Field Effects in Biosystems II; Allen, M.J., Ed.; Plenum Press: New York, 1990; 241-250.